Cargando…

Evaluation of Antidiabetic and Antihyperlipidemic Activity of 80% Methanolic Extract of the Root of Solanum incanum Linnaeus (Solanaceae) in Mice

BACKGROUND: Conventional antidiabetic drugs are linked with a number of contraindications and untoward effects. The root decoction of Solanum incanum L. has traditionally been used to treat diabetes. However, its safety and efficacy have not been scientifically authenticated yet. Hence, the study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Andargie, Yared, Sisay, Woretaw, Molla, Mulugeta, Tessema, Getaye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239786/
https://www.ncbi.nlm.nih.gov/pubmed/35774744
http://dx.doi.org/10.1155/2022/4454881
_version_ 1784737380551360512
author Andargie, Yared
Sisay, Woretaw
Molla, Mulugeta
Tessema, Getaye
author_facet Andargie, Yared
Sisay, Woretaw
Molla, Mulugeta
Tessema, Getaye
author_sort Andargie, Yared
collection PubMed
description BACKGROUND: Conventional antidiabetic drugs are linked with a number of contraindications and untoward effects. The root decoction of Solanum incanum L. has traditionally been used to treat diabetes. However, its safety and efficacy have not been scientifically authenticated yet. Hence, the study was conducted in mice to corroborate its antidiabetic potential and safety profile. METHODS: Using normoglycemic, oral glucose-loaded, and streptozotocin-induced diabetic mice models, the hypoglycemic and antihyperglycemic activities of 80% methanolic root extract were investigated. On streptozotocin-induced diabetic mice, the effect of the test extract on diabetic lipid profile and body weight was also investigated. Further, the in vitro α-amylase inhibition activity was assessed. RESULTS: The test extract was safe at a limit test dose of 2 g/kg. Dose-dependent α-amylase inhibition activity was seen with peak percentage inhibition of 75.95% at 700 μg/mL. In normoglycemic mice, the plant extract showed statistically significant hypoglycemic activity at 200 and 400 mg/kg (P < 0.001) at 6  h and 4 and 6 h of treatment, respectively; in oral glucose-loaded mice, at both the test doses, the glucose level was also significantly dropped at 120 (P < 0.01) and 60 and 120 min (P < 0.001), respectively; whereas, in the third model, the test extract showed significant antihyperglycemic activity at 100 mg/kg (P < 0.05) on the 14(th) day and at 200 (P < 0.01) and 400 mg/kg (P < 0.001) on the 7(th) and 14(th) day of treatment. Similarly, following repeated administration of the test extract at 200 and 400 mg/kg, the body weight was significantly improved on the 14(th) day (P < 0.05) and on the 7(th) and 14(th) day (P < 0.01), respectively, while diabetic dyslipidemia after 14 days (P < 0.05). CONCLUSION: The study revealed that the test extract showed promising antihyperglycemic and antihyperlipidemic activity. Thus, the findings back up its use in Ethiopian remedies for diabetes.
format Online
Article
Text
id pubmed-9239786
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92397862022-06-29 Evaluation of Antidiabetic and Antihyperlipidemic Activity of 80% Methanolic Extract of the Root of Solanum incanum Linnaeus (Solanaceae) in Mice Andargie, Yared Sisay, Woretaw Molla, Mulugeta Tessema, Getaye Evid Based Complement Alternat Med Research Article BACKGROUND: Conventional antidiabetic drugs are linked with a number of contraindications and untoward effects. The root decoction of Solanum incanum L. has traditionally been used to treat diabetes. However, its safety and efficacy have not been scientifically authenticated yet. Hence, the study was conducted in mice to corroborate its antidiabetic potential and safety profile. METHODS: Using normoglycemic, oral glucose-loaded, and streptozotocin-induced diabetic mice models, the hypoglycemic and antihyperglycemic activities of 80% methanolic root extract were investigated. On streptozotocin-induced diabetic mice, the effect of the test extract on diabetic lipid profile and body weight was also investigated. Further, the in vitro α-amylase inhibition activity was assessed. RESULTS: The test extract was safe at a limit test dose of 2 g/kg. Dose-dependent α-amylase inhibition activity was seen with peak percentage inhibition of 75.95% at 700 μg/mL. In normoglycemic mice, the plant extract showed statistically significant hypoglycemic activity at 200 and 400 mg/kg (P < 0.001) at 6  h and 4 and 6 h of treatment, respectively; in oral glucose-loaded mice, at both the test doses, the glucose level was also significantly dropped at 120 (P < 0.01) and 60 and 120 min (P < 0.001), respectively; whereas, in the third model, the test extract showed significant antihyperglycemic activity at 100 mg/kg (P < 0.05) on the 14(th) day and at 200 (P < 0.01) and 400 mg/kg (P < 0.001) on the 7(th) and 14(th) day of treatment. Similarly, following repeated administration of the test extract at 200 and 400 mg/kg, the body weight was significantly improved on the 14(th) day (P < 0.05) and on the 7(th) and 14(th) day (P < 0.01), respectively, while diabetic dyslipidemia after 14 days (P < 0.05). CONCLUSION: The study revealed that the test extract showed promising antihyperglycemic and antihyperlipidemic activity. Thus, the findings back up its use in Ethiopian remedies for diabetes. Hindawi 2022-06-21 /pmc/articles/PMC9239786/ /pubmed/35774744 http://dx.doi.org/10.1155/2022/4454881 Text en Copyright © 2022 Yared Andargie et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Andargie, Yared
Sisay, Woretaw
Molla, Mulugeta
Tessema, Getaye
Evaluation of Antidiabetic and Antihyperlipidemic Activity of 80% Methanolic Extract of the Root of Solanum incanum Linnaeus (Solanaceae) in Mice
title Evaluation of Antidiabetic and Antihyperlipidemic Activity of 80% Methanolic Extract of the Root of Solanum incanum Linnaeus (Solanaceae) in Mice
title_full Evaluation of Antidiabetic and Antihyperlipidemic Activity of 80% Methanolic Extract of the Root of Solanum incanum Linnaeus (Solanaceae) in Mice
title_fullStr Evaluation of Antidiabetic and Antihyperlipidemic Activity of 80% Methanolic Extract of the Root of Solanum incanum Linnaeus (Solanaceae) in Mice
title_full_unstemmed Evaluation of Antidiabetic and Antihyperlipidemic Activity of 80% Methanolic Extract of the Root of Solanum incanum Linnaeus (Solanaceae) in Mice
title_short Evaluation of Antidiabetic and Antihyperlipidemic Activity of 80% Methanolic Extract of the Root of Solanum incanum Linnaeus (Solanaceae) in Mice
title_sort evaluation of antidiabetic and antihyperlipidemic activity of 80% methanolic extract of the root of solanum incanum linnaeus (solanaceae) in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239786/
https://www.ncbi.nlm.nih.gov/pubmed/35774744
http://dx.doi.org/10.1155/2022/4454881
work_keys_str_mv AT andargieyared evaluationofantidiabeticandantihyperlipidemicactivityof80methanolicextractoftherootofsolanumincanumlinnaeussolanaceaeinmice
AT sisayworetaw evaluationofantidiabeticandantihyperlipidemicactivityof80methanolicextractoftherootofsolanumincanumlinnaeussolanaceaeinmice
AT mollamulugeta evaluationofantidiabeticandantihyperlipidemicactivityof80methanolicextractoftherootofsolanumincanumlinnaeussolanaceaeinmice
AT tessemagetaye evaluationofantidiabeticandantihyperlipidemicactivityof80methanolicextractoftherootofsolanumincanumlinnaeussolanaceaeinmice